close
close

STIFEL awards SANOFI a ‘Buy’ STIFEL awards SANOFI a ‘Buy’

STIFEL awards SANOFI a ‘Buy’ STIFEL awards SANOFI a ‘Buy’

FRANKFURT (dpa-AFX Analyser) – The investment bank has extended the financing for Sanofi after investigating the drug tolebrutinib in two application ranges to “Buy” at a price of 111 Eu …